DNA Ploidy, Cell Kinetics, and Epidermal Growth Factor Receptor and HER2/neu Oncoprotein Expression in Primary Operable Breast Cancera
- 1 April 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 784 (1) , 472-481
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancerInternational Journal of Cancer, 1994
- Proliferation of human colon cancer cells: Role of epidermal growth factor and transforming growth factorαInternational Journal of Cancer, 1992
- Production and Characterization of Murine mAbs to the Extracellular Domain of Human Neu Oncogene Product GP185 HER2Hybridoma, 1992
- DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised studyEuropean Journal of Cancer, 1992
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal of Cancer, 1992
- Flow Cytometric DNA Index and S-Phase Fraction in Breast Cancer in Relation to Other Prognostic Variables and to Clinical OutcomeActa Oncologica, 1992
- Feasibility and reproducibility of the [3H]‐thymidine labelling index in breast cancerCell Proliferation, 1991
- Comparison of gaussian and t-distribution densities for modeling fluorescence dispersion in flow cytometric DNA histogramsCytometry, 1991
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Prognostic factors for recurrence and survival in human breast cancerBreast Cancer Research and Treatment, 1987